Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Drop in Short Interest

Aditxt, Inc. (NASDAQ:ADTX) saw a significant decline in short interest in the month of March. As of March 13th, there was short interest totaling 44,231 shares, a decline of 38.3% from the February 26th total of 71,675 shares. Currently, 48.6% of the shares of the company are short sold. Based on an average daily volume of 167,388 shares, the days-to-cover ratio is currently 0.3 days.

Aditxt Stock Performance

Shares of NASDAQ ADTX opened at $0.81 on Friday. The firm has a market capitalization of $72,900.00, a P/E ratio of 0.00 and a beta of 1.53. Aditxt has a one year low of $0.80 and a one year high of $5,324.92. The company’s fifty day moving average is $4.47 and its two-hundred day moving average is $168.36.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aditxt in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.